Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model

BACKGROUND: Spironolactone can improve endothelial dysfunction in the setting of heart failure and diabetes models. However, its beneficial effect in the cardiovascular system is not clear in the setting of non-diabetic renal failure. We conducted this study to investigate whether spironolactone can...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun-Cheng, Lee, An-Sheng, Liu, Shu-Hui, Chang, Kuan-Cheng, Shen, Ming-Yi, Chang, Chiz-Tzung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729054/
https://www.ncbi.nlm.nih.gov/pubmed/31492107
http://dx.doi.org/10.1186/s12882-019-1534-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729054/
https://www.ncbi.nlm.nih.gov/pubmed/31492107
http://dx.doi.org/10.1186/s12882-019-1534-4

Ejemplares similares